An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

Walter Peeler's journey of resilience after a workplace accident is captured in the 'Portraits of Hope' gallery at the ...

Researches at the University of Cincinnati's Gardner Neuroscience Institute could have discovered a new oral treatment that ...

Overview of Medical Exoskeleton MarketThe Global Medical Exoskeleton Market is valued at USD 1.09 Billion in 2024 and is ...

Haxor is an adaptive clothing brand founded by Kkanchan Gupta. It ensures dignity, comfort and independence for the elderly, ...

Living with a physical limitation can be challenging, especially for those who were physically active before an accident. The ...

New biomarkers enhance multiple sclerosis (MS) diagnosis, enabling earlier detection and improved patient care, transforming MS management across the health care system.

Panelists discuss how payers can evaluate BTK inhibitors by considering specific MS phenotypes and FDA indications rather ...

Neural organoids have a habit of sticking to each other, making them hard to scale. Xanthan gum, a common food additive, ...